Yep your right Cw :) Just seen this tweet from Fda....of course someone quote tweet $Rvvtf to it lol... Existing emergency use authorizations (EUAs) for products will remain in effect and the agency may continue to issue new EUAs going forward when criteria for issuance are met.
Existing emergency use authorizations (EUAs) for products will remain in effect and the agency may continue to issue new EUAs going forward when criteria for issuance are met.
Emergency use authorizations (EUAs) The dual emergencies aren’t the only ones in place to respond to COVID-19: The HHS Secretary also granted EUA power to the FDA to streamline availability of new COVID-19 drugs. The end of the dual emergencies does not affect the EUAs that the FDA granted to some COVID-19 vaccines and antiviral drugs like Paxlovid.
The emergency declaration behind the EUAs is issued by the HHS Secretary, and remains in effect until the Secretary decides to terminate it. If the emergency EUA declaration ends, then any medications authorized under it may no longer be available. The drugs would have to receive full FDA approval in order to make it to market again. In a statement, the FDA says that if that occurs, it would allow enough time for the transition to ensure that approvals of the drugs are forthcoming. https://www.msn.com/en-us/news/other/the-u-s-covid-19-public-health-emergency-ends-in-may-here-s-what-will-change/ar-AA16XC0j